Dyadic Applied BioSolutions DYAI reported its 2025

New Post Public Reply Private Reply Replies (0) Message Board Keep
WALL STREET SIGNALS
22
Post of 5,693
Dyadic Applied BioSolutions DYAI reported its 2025 financial results, highlighting key achievements in expanding market access and product launches. President Joe Hazelton emphasized progress with partnerships and new products, including AlbuFree™ DX, aimed at generating recurring revenue.

https://dyadic.com/dyadic-announces-2025-fina...-progress/

Scroll down for more posts ▼